CN104258055A - Preparation method of heatstroke relieving agent used in outdoor power operations - Google Patents
Preparation method of heatstroke relieving agent used in outdoor power operations Download PDFInfo
- Publication number
- CN104258055A CN104258055A CN201410464520.8A CN201410464520A CN104258055A CN 104258055 A CN104258055 A CN 104258055A CN 201410464520 A CN201410464520 A CN 201410464520A CN 104258055 A CN104258055 A CN 104258055A
- Authority
- CN
- China
- Prior art keywords
- parts
- heatstroke
- relieving agent
- preparation
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010019345 Heat stroke Diseases 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 25
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 11
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 6
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 6
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 6
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 6
- 241000405414 Rehmannia Species 0.000 claims abstract description 6
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 6
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 6
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 6
- 244000205574 Acorus calamus Species 0.000 claims abstract description 5
- 235000006480 Acorus calamus Nutrition 0.000 claims abstract description 5
- 241001546929 Campsis grandiflora Species 0.000 claims abstract description 5
- 240000006766 Cornus mas Species 0.000 claims abstract description 5
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 5
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 5
- 235000003805 Musa ABB Group Nutrition 0.000 claims abstract description 5
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract description 5
- 244000242564 Osmanthus fragrans Species 0.000 claims abstract description 5
- 235000019083 Osmanthus fragrans Nutrition 0.000 claims abstract description 5
- 244000170916 Paeonia officinalis Species 0.000 claims abstract description 5
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 5
- 235000015266 Plantago major Nutrition 0.000 claims abstract description 5
- 241001080798 Polygala tenuifolia Species 0.000 claims abstract description 5
- 244000197580 Poria cocos Species 0.000 claims abstract description 5
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 5
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 5
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 5
- 235000011477 liquorice Nutrition 0.000 claims abstract description 5
- 241000758794 Asarum Species 0.000 claims abstract description 4
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 4
- 240000002948 Ophiopogon intermedius Species 0.000 claims abstract description 4
- 241000756042 Polygonatum Species 0.000 claims abstract description 4
- 240000001949 Taraxacum officinale Species 0.000 claims abstract 2
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 9
- 229940126062 Compound A Drugs 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 6
- 241000096284 Gynochthodes officinalis Species 0.000 claims description 5
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 241000735527 Eupatorium Species 0.000 claims description 4
- 240000000249 Morus alba Species 0.000 claims description 4
- 240000007651 Rubus glaucus Species 0.000 claims description 4
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 4
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 4
- 235000008326 Trichosanthes anguina Nutrition 0.000 claims description 4
- 244000078912 Trichosanthes cucumerina Species 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 235000013719 Houttuynia cordata Nutrition 0.000 claims description 2
- 241001633680 Polygonatum odoratum Species 0.000 claims 1
- 244000235659 Rubus idaeus Species 0.000 claims 1
- 208000007180 Sunstroke Diseases 0.000 claims 1
- 235000021018 plums Nutrition 0.000 claims 1
- 235000021013 raspberries Nutrition 0.000 claims 1
- 238000011282 treatment Methods 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 9
- 241000605445 Anemarrhena asphodeloides Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 235000003363 Cornus mas Nutrition 0.000 abstract 1
- 241000308663 Eupatorium fortunei Species 0.000 abstract 1
- 241000218231 Moraceae Species 0.000 abstract 1
- 241000157491 Morinda Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 241000123889 Rubus chingii Species 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 235000017524 noni Nutrition 0.000 abstract 1
- 230000036760 body temperature Effects 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 241000628997 Flos Species 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241001649190 Campsis Species 0.000 description 3
- 206010010071 Coma Diseases 0.000 description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 241000245665 Taraxacum Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 208000032023 Signs and Symptoms Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 241001529821 Agastache Species 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000025599 Heat Stress disease Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000034486 Multi-organ failure Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010035669 Pneumonia aspiration Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010054786 Skin burning sensation Diseases 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000703 anti-shock Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 201000009807 aspiration pneumonia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000021172 family meals Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000008383 multiple organ dysfunction Effects 0.000 description 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000028016 temperature homeostasis Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a preparation method of a heatstroke relieving agent used in outdoor power operations. The following raw materials are used in the method: 35 parts of salvia miltiorrhiza, 35 parts of asiatic cornelian cherry fruit, 35 parts of lotus leaves, 30 parts of spina date seed, 30 parts of dark plum, 25 parts of heartleaf houttuynia herb, 25 parts of prepared rehmannia root, 22 parts of dwarf lilyturf tuber, 22 parts of osmanthus fragrans, 22 parts of white paeony root, 22 parts of eupatorium fortunei, 22 parts of dandelion, 20 parts of Indian bread, 20 parts of dried tangerine peel, 20 parts of polygala tenuifolia, 20 parts of acorus calamus, 18 parts of trichosanthes kirilowii Maxim, 18 parts of mulberries, 18 parts of campsis grandiflora, 18 parts of palmleaf raspberry fruit, 15 parts of fragrant solomonseal rhizome, 15 parts of Chinese magnoliavine fruit, 15 parts of common anemarrhena rhizome, 10 parts of morinda root, 8 parts of plantain herb and 8 parts of liquorice. The preparation method has the beneficial effects that the medicines are jointly used and complement each other; the heatstroke relieving agent has obvious and stable heatstroke treatment effects and broad application prospects.
Description
Technical Field
The invention belongs to the technical field of health care products, and particularly relates to a preparation method of a summer-heat relieving agent for outdoor power operation.
Background
In full summer, the summer heat is hard to endure, in order to ensure the normal power supply in the peak period of power utilization in summer, a power company needs to invest a large amount of manpower and material resources every year, test and adjustment of the load of a public transformer are performed, multiple times of inspection of circuits and equipment in a power supply area are organized, the hidden dangers, defects, illegal buildings and the like which can endanger the power supply safety are rectified and improved in time, about 2.5 million employees in a system of the power company in Shandong province work outdoors and outdoors at every year, the power company tries to work for keeping the power supply, an electric power worker who works outdoors cannot enter the grid when wearing three quarters, wears a safety helmet, wears long sleeves and trousers, wears leather gloves on the arms, buckles tight collars, often pushes away the summer heat, suffers from burning sun, works aloft outdoors for a long time, is common family meal of the people, and heatstroke medicines are common medicines for the people, the medicine is taken immediately after discomfort is found, and the patient is rested and then put on the table.
Heatstroke is a common emergency in summer and is a general term for the symptoms of body thermoregulation disturbance, water and electrolyte metabolism disorder and nervous system function damage under the long-term action of high temperature and heat radiation. When the heat production of a human body is greater than the heat dissipation, the heat accumulation in the human body causes the central control of the regulation of the body temperature, the cardiac function is reduced, the cardiac output is reduced, the central venous pressure is increased, the sweat gland function is exhausted, the heat in the human body is further accumulated, the body temperature rises suddenly in a short time, when the body temperature is higher than 41.5 ℃, the high heat causes damage to multiple organs, tissue cell membranes and internal structures of cells, the cell membranes have poor stability, the oxidative phosphorylation of mitochondria is obstructed, the oxygen-dependent metabolic pathway is damaged, the tissue is anoxic, the permeability of tissue capillaries is increased, edema, microcirculation obstruction, water electrolysis of alkali hyaluronate is disturbed, and the multiple organ dysfunction of the heart, the lung, the brain, the kidney, the liver and the like. The reasons for heatstroke are many, except for high temperature and burning sun, the common causes of overstrain, over-dense people, over-strong working strength, over-long time, insufficient sleep, over-fatigue and the like.
The degree of heatstroke can be divided into three stages: the premonitory heatstroke. In high temperature environment, excessive sweating, thirst, dizziness, tinnitus, chest distress, cardiopalmus, nausea, myasthenia of limbs, and inattention, with body temperature not more than 37.5 deg.C; ② mild heatstroke. Has the symptoms of premonitory heatstroke, simultaneously has the body temperature of over 38.5 ℃, and is accompanied with the phenomena of flushing, chest distress, burning skin and the like; or skin wetness and coldness, emesis, blood pressure decrease, and fine and rapid pulse; ③ severe heatstroke. In addition to the above symptoms, syncope or spasm occurs; or no sweating, and body temperature above 40 deg.C. A large amount of dust, which is very high in free silica, is inhaled into the lungs and often cannot be removed from the respiratory tract in a timely and complete manner. Sometimes, though the heatstroke symptom does not appear, the heatstroke appears after a plurality of years after the work is removed, and the heatstroke is often called as 'late heatstroke'; even if the patient in early heatstroke breaks away from dust work, the condition can continue to develop, if no complications exist, the patient can live for a long time, but the patient often loses the labor capacity.
At present, the treatment of the emergency treatment mainly aims at treating secondary symptoms, replenishing water and fluid, injecting chlorpromazine into severe muscles, and the traditional Chinese medicine has deep research on heatstroke and belongs to the categories of summer-heat and summer-heat syncope. Summer-heat refers to an acute febrile disease with rapid transmission in the course of disease, which is caused by pathogenic summer-heat, manifested as high fever, polydipsia, sweating, surging pulse and other syndromes of yang-qi system with extreme heat, and is liable to damage the body fluid and consume qi, and frequent obstruction of the orifices and stirring wind. The occurrence of summer-heat is caused by pathogenic summer-heat induced by attack from the exterior and by deficiency of the healthy qi of the body. Summer-heat is pathogenic fire, heart is fire, and summer-heat is usually absorbed by heart, so in summer-heat process, summer-heat tends to sink heart-ying. In addition, summer-heat can also suddenly block the pericardium, leading to sudden coma, "summer-heat faint", manifested as burning, restlessness, coma, sudden coma, unconsciousness, dyspnea, slight tense of the tooth joints, convulsion of the limbs, deep red tongue and thready and rapid pulse. The pathogenic factors of summer-heat are the exogenous factors causing heatstroke, while the deficiency of healthy qi is the endogenous factor causing the invasion of exogenous factors. Summer heat is moderate in summer, the temperature is high, the humidity is high, if the body consumes body fluid due to insufficient healthy qi or excessive fatigue, summer heat can invade the body to cause disease, the heatstroke is clinically treated, and the traditional Chinese medicine with the effects of tonifying qi and promoting the production of body fluid is applied to treat the disease and seek the foundation, so that the clinical effect is better.
Disclosure of Invention
The invention refers to the understanding of the pathogenesis of the summer-heat warm disease and the precious experience of treatment in traditional Chinese medicine, refers to the existing reasonable formula, treats based on syndrome differentiation, and is improved to some extent according to the Chinese pharmacopoeia and pharmacological compatibility. The inventor selects natural ingredients for tonifying qi, promoting the production of body fluid and inducing resuscitation and cooling from the Chinese medical treasury by researching the traditional Chinese medicine and combining dialectical argument and collecting the advantages of many people, seeks an optimal treatment scheme, extracts essence according to the formula of the traditional Chinese medicine theory, elaborately prepares the preparation for treating heatstroke, which is disclosed by the invention, by combining the traditional Chinese medicine technology, has an obvious effect compared with western medicines, and treats both principal and secondary aspects of diseases.
In order to realize the purpose of the invention, the technical scheme adopted by the invention is as follows:
a preparation method of a summer-heat relieving agent for outdoor power operation is characterized by being prepared from the following raw materials in parts by weight:
30-35 parts of salvia miltiorrhiza, 30-35 parts of dogwood, 30-35 parts of lotus leaf, 25-30 parts of spina date seed, 25-30 parts of dark plum fruit,
22-25 parts of houttuynia cordata, 22-25 parts of prepared rehmannia root, 20-22 parts of radix ophiopogonis, 20-22 parts of sweet osmanthus, 20-22 parts of white paeony root,
20-22 parts of eupatorium, 20-22 parts of dandelion, 18-20 parts of poria cocos, 18-20 parts of dried orange peel, 18-20 parts of polygala tenuifolia,
18-20 parts of acorus calamus, 15-18 parts of snakegourd fruit, 15-18 parts of mulberry, 15-18 parts of campsis grandiflora, 15-18 parts of raspberry,
10-15 parts of radix polygonati officinalis, 10-15 parts of schisandra chinensis, 10-15 parts of rhizoma anemarrhenae, 8-10 parts of morinda officinalis, 5-8 parts of plantain herb, and,
5-8 parts of liquorice.
The preparation method of the heatstroke relieving agent comprises the following steps: the raw material medicines (such as the proportioning unit: g) in parts by weight are taken to prepare the capsule, and the specific operation is as follows:
1) weighing the raw materials for later use;
2) adding 5 times of water into Saviae Miltiorrhizae radix, folium Nelumbinis, semen Ziziphi Spinosae, mume fructus, herba Houttuyniae, radix rehmanniae Preparata, radix Ophiopogonis, Rubi fructus, rhizoma Polygonati Odorati, fructus Schisandrae chinensis, rhizoma anemarrhenae and radix Morindae officinalis, boiling with strong fire, decocting with slow fire for 1 hr, filtering, and collecting filtrate and residue; adding water into the filter residue, boiling with strong fire until the residue is not filtered, decocting with slow fire for 30 minutes, filtering, and collecting the filtrate; mixing the above two filtrates, cooling, and concentrating to obtain extract with density of 1.2 g/ml; drying at 80 ℃, and crushing into powder to obtain a compound A;
3) taking the rest components: soaking Corni fructus, flos Osmanthi Fragrantis, radix Paeoniae alba, herba Eupatorii, herba Taraxaci, Poria, pericarpium Citri Tangerinae, cortex et radix Polygalae, rhizoma Acori Calami, fructus Trichosanthis, Mori fructus, flos Campsis, herba plantaginis, and Glycyrrhrizae radix in 70% ethanol for 1.5 hr, extracting twice (each for 1-2 hr), mixing extractive solutions, filtering, concentrating into extract with density of 1.2g/ml, drying, and pulverizing to obtain compound B;
4) mixing compound A and compound B, stirring, sterilizing, and making into capsule, 0.5g for oral administration, twice a day.
The components of the heatstroke relieving agent are all natural traditional Chinese medicine raw materials, the preparation is simple and convenient, the medicine source is wide, the cost is low, the traditional Chinese medicine prescription and the medicine principle are followed, the medicines are combined, the best is obtained, the effects of the medicines are exerted by monarch, minister, assistant and guide, the purpose of treating heatstroke can be effectively achieved, and the clinical application verifies that the heatstroke relieving agent has obvious and reliable curative effect, flat medicine property and wide application prospect.
Detailed Description
Example 1
A preparation method of a summer-heat relieving agent for treating outdoor power operation is disclosed, wherein the summer-heat relieving agent is prepared from the following raw materials in parts by weight:
30 parts of salvia miltiorrhiza, 30 parts of dogwood, 30 parts of lotus leaf, 25 parts of spina date seed, 25 parts of dark plum fruit,
22 parts of heartleaf houttuynia herb, 22 parts of prepared rehmannia root, 20 parts of dwarf lilyturf tuber, 20 parts of sweet osmanthus flower, 20 parts of white paeony root,
20 parts of eupatorium, 20 parts of dandelion, 18 parts of poria cocos, 18 parts of dried orange peel, 18 parts of polygala tenuifolia,
18 parts of acorus calamus, 15 parts of snakegourd fruit, 15 parts of mulberry, 15 parts of campsis grandiflora, 15 parts of raspberry,
10 parts of polygonatum, 10 parts of schisandra, 10 parts of rhizoma anemarrhenae, 8 parts of morinda officinalis, 5 parts of plantain herb, and,
And 5 parts of liquorice.
The preparation method of the heatstroke relieving agent comprises the following steps: the raw material medicines (such as the proportioning unit: g) in parts by weight are taken to prepare the capsule, and the specific operation is as follows:
1) weighing the raw materials for later use;
2) adding 5 times of water into Saviae Miltiorrhizae radix, folium Nelumbinis, semen Ziziphi Spinosae, mume fructus, herba Houttuyniae, radix rehmanniae Preparata, radix Ophiopogonis, Rubi fructus, rhizoma Polygonati Odorati, fructus Schisandrae chinensis, rhizoma anemarrhenae and radix Morindae officinalis, boiling with strong fire, decocting with slow fire for 1 hr, filtering, and collecting filtrate and residue; adding water into the filter residue, boiling with strong fire until the residue is not filtered, decocting with slow fire for 30 minutes, filtering, and collecting the filtrate; mixing the above two filtrates, cooling, and concentrating to obtain extract with density of 1.2 g/ml; drying at 80 ℃, and crushing into powder to obtain a compound A;
3) taking the rest components: soaking Corni fructus, flos Osmanthi Fragrantis, radix Paeoniae alba, herba Eupatorii, herba Taraxaci, Poria, pericarpium Citri Tangerinae, cortex et radix Polygalae, rhizoma Acori Calami, fructus Trichosanthis, Mori fructus, flos Campsis, herba plantaginis, and Glycyrrhrizae radix in 70% ethanol for 1.5 hr, extracting twice (each for 1-2 hr), mixing extractive solutions, filtering, concentrating into extract with relative density of 1.2, drying, and pulverizing to obtain compound B;
4) mixing compound A and compound B, stirring, sterilizing, and making into capsule, 0.5g for oral administration, twice a day.
Example 2
A preparation method of a summer-heat relieving agent for outdoor power operation is disclosed, wherein the summer-heat relieving agent is prepared from the following raw materials in parts by weight:
35 parts of salvia miltiorrhiza, 35 parts of dogwood, 35 parts of lotus leaf, 30 parts of spina date seed, 30 parts of dark plum fruit,
25 parts of heartleaf houttuynia herb, 25 parts of prepared rehmannia root, 22 parts of dwarf lilyturf tuber, 22 parts of sweet osmanthus flower, 22 parts of white paeony root,
22 parts of eupatorium, 22 parts of dandelion, 20 parts of poria cocos, 20 parts of dried orange peel, 20 parts of polygala tenuifolia,
20 parts of acorus calamus, 18 parts of snakegourd fruit, 18 parts of mulberry, 18 parts of campsis grandiflora, 18 parts of raspberry,
15 parts of polygonatum, 15 parts of schisandra, 15 parts of rhizoma anemarrhenae, 10 parts of morinda officinalis, 8 parts of plantain herb, and,
8 parts of liquorice.
The preparation method of the heatstroke relieving agent comprises the following steps: the raw material medicines (such as the proportioning unit: g) in parts by weight are taken to prepare the capsule, and the specific operation is as follows:
1) weighing the raw materials for later use;
2) adding 5 times of water into Saviae Miltiorrhizae radix, folium Nelumbinis, semen Ziziphi Spinosae, mume fructus, herba Houttuyniae, radix rehmanniae Preparata, radix Ophiopogonis, Rubi fructus, rhizoma Polygonati Odorati, fructus Schisandrae chinensis, rhizoma anemarrhenae and radix Morindae officinalis, boiling with strong fire, decocting with slow fire for 1 hr, filtering, and collecting filtrate and residue; adding water into the filter residue, boiling with strong fire until the residue is not filtered, decocting with slow fire for 30 minutes, filtering, and collecting the filtrate; mixing the above two filtrates, cooling, and concentrating to obtain extract with density of 1.2 g/ml; drying at 80 ℃, and crushing into powder to obtain a compound A;
3) taking the rest components: soaking Corni fructus, flos Osmanthi Fragrantis, radix Paeoniae alba, herba Eupatorii, herba Taraxaci, Poria, pericarpium Citri Tangerinae, cortex et radix Polygalae, rhizoma Acori Calami, fructus Trichosanthis, Mori fructus, flos Campsis, herba plantaginis, and Glycyrrhrizae radix in 70% ethanol for 1.5 hr, extracting twice (each for 1-2 hr), mixing extractive solutions, filtering, concentrating into extract with relative density of 1.2, drying, and pulverizing to obtain compound B;
4) mixing compound A and compound B, stirring, sterilizing, and making into capsule, 0.5g for oral administration, twice a day.
Example 3
Toxicity test
In the experiment, healthy SD rats are respectively orally administered with the heatstroke relieving agent prepared in the embodiment 1 and the embodiment 2 for 30 days, and the growth state, active diet, hematology, blood biochemistry, organ tissue structure, urine convention and the like of animals have no obvious influence during the administration period of the rats and within 1 week after the administration is stopped, so that the clinical medication is safe and reliable.
Example 4
Clinical data
90 diagnosed heatstroke patients were randomly divided into 45 cases each of the treatment group and the control group. The age, sex and severity of illness of the two groups of patients have no obvious difference and are comparable.
The inclusion criteria of cases were: meets the national sanitary standard of the people's republic of China (GB 11508-; the traditional Chinese medicine composition has a history of high-temperature environment contact, the body temperature is more than or equal to 40 ℃, the body temperature rise caused by other reasons is eliminated, various clinical symptoms of heatstroke are achieved, and severe heatstroke symptoms do not appear in the above cases.
Method of treatment
The control group orally takes herba Agastaches decoction for treatment of hypertension, 2 times per day; the treatment group orally administered 0.5g of the heatstroke relieving agent prepared in example 1 twice a day.
The therapeutic effect judgment standard is as follows: is formulated according to the standard of curative effect of diagnosis of internal medical diseases of traditional Chinese medicine formulated by the State administration of traditional Chinese medicine.
And (3) curing: the symptoms and signs disappear, and the spirit recovers. Improvement: the symptoms and signs are basically disappeared, and the physical strength is not completely recovered. The disease is not cured: no improvement or worsening of symptoms was evident:
statistical treatment:
using SPSS13.0 statistical software to process data, expressing the measured data by mean +/-standard deviation, using t test, and using x as counting data2And (6) checking.
Results
Clinical efficacy comparisons, statistical data processing was performed using SPSS13.0 statistical software, and the data are shown in table 1:
TABLE 1
Example 5
The invention is used for clinical data of severe heatstroke
51 severe heatstroke patients for emergency treatment are selected, and all patients meet the severe heatstroke typing standard of 5 th edition of internal science. Patients are randomly divided into a treatment group and a control group, wherein the treatment group comprises 26 patients and the control group comprises 25 patients, and the comparison difference of the patients in the two groups in terms of age, sex, disease conditions and the like has no statistical significance (P > 0.05) and is comparable.
The two groups of patients are treated in an emergency after hospitalization, including physical cooling, respiratory and circulation maintaining, water electrolyte disorder and acid-base balance disorder correcting, multi-organ failure preventing and treating, rapid venous transfusion, antishock and hydration treatment; simultaneously, mannitol is given to accelerate urine dehydration, alkalize urine, prevent infection, wake up, stabilize cell membrane, and give vitamin C as antioxidant, protect gastric mucosa, promote gastrointestinal motility, support nutrition, etc. The treatment scheme of the treatment group is to add the medicinal preparation obtained in the example 2 of the invention on the basis of the comprehensive treatment.
The mental recovery time, the body temperature recovery time and the hospitalization time of the patients are observed, the clinical treatment effect of the two groups of patients is evaluated, and the adverse drug reactions are recorded.
The therapeutic effect judgment standard is as follows: the effect is shown: the patient is conscious within 4h, and the blood pressure, pulse, respiration and body temperature are all recovered to be normal, and all the inspection indexes are all normal.
The method has the following advantages: after 4 hours, the patient is conscious within 8 hours, the blood pressure, the pulse, the respiration and the body temperature are recovered to be normal, and various test indexes tend to be normal.
And (4) invalidation: after 8 hours, the patient has mild disturbance of consciousness, high body temperature and complications such as liver and kidney function damage, aspiration pneumonia and the like.
Statistical analysis was performed with SPSS13.0, P < 0.05 indicating significance. The results are shown in Table 2
TABLE 2
Group of | Number of examples | Show effect | Is effective | Invalidation | Total effective rate |
EXAMPLE 2 group | 26 | 19 | 6 | 1 | 96% |
Control group | 25 | 13 | 4 | 8 | 68% |
The fever time and symptom sign improvement time of the treatment group are obviously faster than those of the control group, especially the fever abatement, the recovery of the disturbance of consciousness and the improvement of headache and dizziness.
Compared with the conventional treatment, the preparation of the invention has the advantages of fast recovery of fever abatement, awakening, multi-organ dysfunction, higher cure rate and no adverse reaction, so the preparation of the invention is a good and safe choice for treating severe heatstroke.
The foregoing list is only illustrative of the preferred embodiments of the present invention. It is obvious that the invention is not limited to the above embodiments, but that many variations are possible. All modifications which can be derived or suggested by a person skilled in the art from the disclosure of the present invention are to be considered within the scope of the invention.
Claims (2)
1. A preparation method of a summer-heat relieving agent for outdoor power operation is characterized by comprising the following steps:
1) weighing the raw material medicines according to the parts by weight for later use; wherein,
35 parts of salvia miltiorrhiza, 35 parts of dogwood, 35 parts of lotus leaf, 30 parts of spina date seed, 30 parts of dark plum fruit,
25 parts of heartleaf houttuynia herb, 25 parts of prepared rehmannia root, 22 parts of dwarf lilyturf tuber, 22 parts of sweet osmanthus flower, 22 parts of white paeony root,
22 parts of eupatorium, 22 parts of dandelion, 20 parts of poria cocos, 20 parts of dried orange peel, 20 parts of polygala tenuifolia,
20 parts of acorus calamus, 18 parts of snakegourd fruit, 18 parts of mulberry, 18 parts of campsis grandiflora, 18 parts of raspberry,
15 parts of polygonatum, 15 parts of schisandra, 15 parts of rhizoma anemarrhenae, 10 parts of morinda officinalis, 8 parts of plantain herb, and,
8 parts of liquorice;
2) adding 5 times of water into salvia miltiorrhiza, lotus leaves, spina date seeds, dark plums, houttuynia cordata, prepared rehmannia roots, radix ophiopogonis, raspberries, polygonatum odoratum, schisandra chinensis, rhizoma anemarrhenae and morinda officinalis, boiling with strong fire, decocting with slow fire for 1 hour, filtering, and collecting filtrate and filter residues; adding water into the filter residue, boiling with strong fire until the residue is not filtered, decocting with slow fire for 30 minutes, filtering, and collecting the filtrate; mixing the above two filtrates, cooling, and concentrating to obtain extract with density of 1.2 g/ml; drying at 80 ℃, and crushing into powder to obtain a compound A;
3) soaking the rest raw materials in 70% ethanol for 1.5 hr, extracting for two times (each for 1-2 hr), mixing extractive solutions, filtering, concentrating to obtain extract with density of 1.2g/ml, drying, and pulverizing to obtain compound B;
4) mixing the compound A and the compound B, stirring uniformly, and sterilizing.
2. Use of the sunstroke-relieving agent prepared by the method of claim 1 for heatstroke.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410464520.8A CN104258055A (en) | 2014-09-13 | 2014-09-13 | Preparation method of heatstroke relieving agent used in outdoor power operations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410464520.8A CN104258055A (en) | 2014-09-13 | 2014-09-13 | Preparation method of heatstroke relieving agent used in outdoor power operations |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104258055A true CN104258055A (en) | 2015-01-07 |
Family
ID=52149712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410464520.8A Pending CN104258055A (en) | 2014-09-13 | 2014-09-13 | Preparation method of heatstroke relieving agent used in outdoor power operations |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104258055A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102986975A (en) * | 2011-12-15 | 2013-03-27 | 陈楚忠 | Clear moisturizing type herbal tea and preparation method thereof |
CN103656558A (en) * | 2012-09-18 | 2014-03-26 | 刘志勇 | Traditional Chinese medicinal composition of heart-fire clearing herbal tea and preparation method thereof |
CN103656557A (en) * | 2012-09-18 | 2014-03-26 | 刘志勇 | Traditional Chinese medicine composition for strengthening brain and soothing nerves and preparation method thereof |
-
2014
- 2014-09-13 CN CN201410464520.8A patent/CN104258055A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102986975A (en) * | 2011-12-15 | 2013-03-27 | 陈楚忠 | Clear moisturizing type herbal tea and preparation method thereof |
CN103656558A (en) * | 2012-09-18 | 2014-03-26 | 刘志勇 | Traditional Chinese medicinal composition of heart-fire clearing herbal tea and preparation method thereof |
CN103656557A (en) * | 2012-09-18 | 2014-03-26 | 刘志勇 | Traditional Chinese medicine composition for strengthening brain and soothing nerves and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102813904A (en) | Compound medicine for treating anaphylactic rhinitis-asthma syndrome and preparation method and application thereof | |
CN101549101A (en) | Traditional Chinese medicine for treating pneumoconiosis and drug-tolerant pulmonary tuberculosis and preparation method thereof | |
CN101579186B (en) | Pharmaceutical rhinitis pillow for external use and treating wind-heat rhinitis | |
CN114732887A (en) | Traditional Chinese medicine composition for treating bronchial asthma | |
CN104352595A (en) | Traditional Chinese medicine for treating allergic rhinitis and preparation method thereof | |
CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
CN101406598B (en) | Chinese medicine composite for treating diabetes and preparation method thereof | |
CN105031454A (en) | Medicine for treating pulmonary tuberculosis | |
CN102188689B (en) | Compound combination medicament for treating COPD, preparation method and application thereof | |
CN105456818A (en) | Traditional Chinese medicine composition containing folium artemisiae argyi and being capable of treating insomnia and preparation method of traditional Chinese medicine composition | |
CN113713009A (en) | Traditional Chinese medicine composition for improving specific endowment constitution and preparation method and application thereof | |
CN103142914B (en) | Traditional Chinese medicine for lowering blood sugar | |
CN102813767B (en) | First-aid drug for treating heatstroke and preparation method thereof | |
CN104258055A (en) | Preparation method of heatstroke relieving agent used in outdoor power operations | |
CN104491318A (en) | Traditional Chinese preparation used for treating asthma and preparation method of traditional Chinese preparation | |
CN104172174B (en) | A kind of preparation preventing electric power open work heatstroke | |
CN104225225A (en) | Method for preparing heatstroke prevention preparation for outdoor power operation | |
CN104606484A (en) | Traditional Chinese medicine composition for treating qi-blood deficiency and preparation method thereof | |
CN104324200A (en) | Traditional Chinese medicine pill for treating senile skin pruritus | |
CN103495022A (en) | Traditional Chinese medicine for adjuvant therapy of aids | |
CN106309920A (en) | Traditional Chinese medicine preparation for relieving fatigue and preparation method thereof | |
CN105770815A (en) | Folium artemisiae argyi-containing traditional Chinese medicine composition for treating postpartum collapse and preparation method thereof | |
CN115444915A (en) | Traditional Chinese medicine composition for treating insomnia and preparation method and application thereof | |
CN104491378A (en) | Method for preparing medicine for treating bronchial asthma | |
CN104258056A (en) | Heatstroke relieving agent used in outdoor power operations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150107 |
|
RJ01 | Rejection of invention patent application after publication |